Table 2

Characteristics, results and diagnosis for patients with Alzheimer's disease, vascular dementia, mixed dementia and other neurological diseases
Sex/age
(years)
 tTau1
(ng/L)
 P-tau2
(ng/L)
 tTau/
P-Tau
 Aβ423
(ng/L)
 14-3-3 protein1
(arbitrary units)
 Diagnosis
Female/59
 2120
 244*
 8
 401*
 M
 AD
Female/64
 2335
 240*
 10
 347*
 0.00
 AD
Female/76
 1400
 220*
 6
 505*
 0.00
 AD
Female/79
 2443
 287*
 9
 517*
 0.00
 AD
Female/85
 1350
 49
 27
 746
 0.59
 MCI
Female/73
 1380
 217*
 6
 743
 0.15
 AD
Female/67
 1410
 199*
 7
 413*
 0.00
 AD
Female/62
 1670
 66
 25
 348*
 0.41
 AD/Wernicke
Female/51
 1410
 27
 52
 697
 0.00
 Possible FTD
Female/66
 1410
 238*
 6
 622
 0.00
 MCI/Possible AD
Female/64
 1750
 49
 36
 926
 0.55
 Possible VaD
Male/65
 1910
 79
 24
 1297
 0.34
 Unspecified dementia
Male/65
 1280
 57
 22
 1244
 0.53
 Possible AD/VaD
Female/62
 3443
 242*
 14
 312*
 0.52
 FTD/Possibly AD
Female/67
 1540
 238*
 6
 369*
 0.00
 Probably AD
Female/88
 2720
 90*
 30
 464*
 0.00
 AD/VaD
Male49
 1350
 81*
 17
 973
 0.00
 VaD
Female/72
 1780
 240*
 7
 533*
 0.00
 AD
Female/80
 1280
 239*
 5
 699
 0.00
 Probably AD
Female/76
 1480
 227*
 7
 516*
 0.00
 AD/VaD
Female/76
 1360
 207*
 7
 573
 0.00
 AD
Male/62
 8,530*
 75
 114
 1043
 0.00
 Cerebral lymphoma
Male/71
 1,202
 59
 20
 487*
 0.00
 Cerebral infarction
Female/69
 1,992
 83*
 24
 674
 0.29
 Cerebral infarction
Female/49
 1,267
 27
 47
 807
 0.95*
 Cerebral lymphoma
Female/32
 1,433
 49
 29
 960
 0.00
 Cerebellitis

1Values above lower limit for CJD marked with*, 2Values above maximum for normal in clinical practice marked with*, 3Values below minimum for normal used in clinical practice marked with*, M = missing value.

Skinningsrud et al. Cerebrospinal Fluid Research 2008 5:14   doi:10.1186/1743-8454-5-14